Terms: = Colorectal cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Treatment
117 results:
1. Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses.
Tapia-Galisteo A; Sánchez-Rodríguez I; Narbona J; Iglesias-Hernández P; Aragón-García S; Jiménez-Reinoso A; Compte M; Khan S; Tsuda T; Chames P; Lacadena J; Álvarez-Vallina L; Sanz L
Oncoimmunology; 2024; 13(1):2338558. PubMed ID: 38623463
[TBL] [Abstract] [Full Text] [Related]
2. B7-H3 Expression in Breast cancer and Brain Metastasis.
Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
[TBL] [Abstract] [Full Text] [Related]
3. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy.
Shebbo S; Binothman N; Darwaish M; Niaz HA; Abdulal RH; Borjac J; Hashem AM; Mahmoud AB
Front Immunol; 2024; 15():1350208. PubMed ID: 38533510
[TBL] [Abstract] [Full Text] [Related]
4. IL-15-secreting car natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.
Van den Eynde A; Gehrcken L; Verhezen T; Lau HW; Hermans C; Lambrechts H; Flieswasser T; Quatannens D; Roex G; Zwaenepoel K; Marcq E; Joye P; Cardenas De La Hoz E; Deben C; Gasparini A; Montay-Gruel P; Le Compte M; Lion E; Lardon F; Van Laere S; Siozopoulou V; Campillo-Davo D; De Waele J; Pauwels P; Jacobs J; Smits E; Van Audenaerde JRM
J Hematol Oncol; 2024 Feb; 17(1):8. PubMed ID: 38331849
[TBL] [Abstract] [Full Text] [Related]
5. Novel immunotherapies for breast cancer: Focus on 2023 findings.
Lan HR; Chen M; Yao SY; Chen JX; Jin KT
Int Immunopharmacol; 2024 Feb; 128():111549. PubMed ID: 38266449
[TBL] [Abstract] [Full Text] [Related]
6. New immunotherapy approaches for colorectal cancer: focusing on car-T cell, BiTE, and oncolytic viruses.
Kamrani A; Nasiri H; Hassanzadeh A; Ahmadian Heris J; Mohammadinasab R; Sadeghvand S; Sadeghi M; Valedkarimi Z; Hosseinzadeh R; Shomali N; Akbari M
Cell Commun Signal; 2024 Jan; 22(1):56. PubMed ID: 38243252
[TBL] [Abstract] [Full Text] [Related]
7. Unraveling the multifaceted role of EpCAM in colorectal cancer: an integrated review of its function and interplay with non-coding RNAs.
Jiang X; Wang S; Liang Q; Liu Y; Liu L
Med Oncol; 2023 Dec; 41(1):35. PubMed ID: 38151631
[TBL] [Abstract] [Full Text] [Related]
8. Cumulative Absolute Risk of Subsequent colorectal cancer After Abdominopelvic Radiotherapy Among Childhood cancer Survivors: A PancareSurFup Study.
Heymer EJ; Jóźwiak K; Kremer LC; Winter DL; de Vathaire F; Sunguc C; Sugden E; Kok JL; van der Pal HJH; Hjorth L; Jakab Z; Maule MM; Haupt R; Bagnasco F; Terenziani M; Diallo I; Gunnes MW; Sommer G; Zadravec Zaletel L; Kuehni CE; Winther JF; Lähteenmäki PM; Gudmundsdottir T; Allodji RS; Skinner R; Ronckers CM; Hawkins MM; Reulen RC; Teepen JC
J Clin Oncol; 2024 Jan; 42(3):336-347. PubMed ID: 37972325
[TBL] [Abstract] [Full Text] [Related]
9. Implications of single-cell immune landscape of tumor microenvironment for the colorectal cancer diagnostics and therapy.
Alzamami A
Med Oncol; 2023 Nov; 40(12):352. PubMed ID: 37950801
[TBL] [Abstract] [Full Text] [Related]
10. Translational research of new developments in targeted therapy of colorectal cancer.
Yang L; Atakhanova N; Arellano MTC; Mohamed MY; Hani T; Fahdil AA; Castillo-Acobo RY; Juyal A; Hussein AK; Amin AH; Pecho RDC; Akhavan-Sigari R
Pathol Res Pract; 2023 Dec; 252():154888. PubMed ID: 37948996
[TBL] [Abstract] [Full Text] [Related]
11. Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment.
He X; Lan H; Jin K; Liu F
Front Immunol; 2023; 14():1237764. PubMed ID: 37790928
[TBL] [Abstract] [Full Text] [Related]
12. The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of car133-NK92 cells in colorectal cancer.
Wang X; Qiu W; Liu H; He M; He W; Li Z; Wu Z; Xu X; Chen P
Cancer Biol Med; 2023 Sep; 20(9):662-81. PubMed ID: 37731205
[TBL] [Abstract] [Full Text] [Related]
13. Pre-clinical validation of a pan-cancer car-T cell immunotherapy targeting nfP2X7.
Bandara V; Foeng J; Gundsambuu B; Norton TS; Napoli S; McPeake DJ; Tyllis TS; Rohani-Rad E; Abbott C; Mills SJ; Tan LY; Thompson EJ; Willet VM; Nikitaras VJ; Zheng J; Comerford I; Johnson A; Coombs J; Oehler MK; Ricciardelli C; Cowin AJ; Bonder CS; Jensen M; Sadlon TJ; McColl SR; Barry SC
Nat Commun; 2023 Sep; 14(1):5546. PubMed ID: 37684239
[TBL] [Abstract] [Full Text] [Related]
14. Preconditioning of radiotherapy enhances efficacy of B7-H3-car-T in treating solid tumor models.
Wang T; Zhang K; You F; Ma R; Yang N; Tian S; An G; Yang L
Life Sci; 2023 Oct; 331():122024. PubMed ID: 37574043
[TBL] [Abstract] [Full Text] [Related]
15. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in colorectal cancer and Invasive Breast cancer.
Cao Y; Efetov SK; He M; Fu Y; Beeraka NM; Zhang J; Zhang X; Bannimath N; Chen K
Arch Immunol Ther Exp (Warsz); 2023 Aug; 71(1):19. PubMed ID: 37566162
[TBL] [Abstract] [Full Text] [Related]
16. T Cells in colorectal cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment.
Zheng Z; Wieder T; Mauerer B; Schäfer L; Kesselring R; Braumüller H
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511431
[TBL] [Abstract] [Full Text] [Related]
17. Tumor-secreted IFI35 promotes proliferation and cytotoxic activity of CD8
Li P; Zhou D; Chen D; Cheng Y; Chen Y; Lin Z; Zhang X; Huang Z; Cai J; Huang W; Lin Y; Ke H; Long J; Zou Y; Ye S; Lan P
J Biomed Sci; 2023 Jun; 30(1):47. PubMed ID: 37380972
[TBL] [Abstract] [Full Text] [Related]
18. Facts and Hopes in colorectal cancer Immunotherapy.
Foote MB; Argilés G; Rousseau B; Segal NH
Clin Cancer Res; 2023 Oct; 29(20):4032-4039. PubMed ID: 37326624
[TBL] [Abstract] [Full Text] [Related]
19. [Specialised treatment of colorectal cancer in certified cancer centres: Do patients really have to travel further?].
Berger E; Reichebner C; Eriksen A; Hildebrandt M; Kuklinski D; Busse R
Gesundheitswesen; 2023 Jul; 85(7):657-666. PubMed ID: 37321253
[TBL] [Abstract] [Full Text] [Related]
20. The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancer.
Meng S; Li M; Qin L; Lv J; Wu D; Zheng D; Jia H; Chen D; Wu Q; Long Y; Tang Z; Tang Y; Yang L; Yao Y; Luo X; Li P
Int Immunopharmacol; 2023 Aug; 121():110402. PubMed ID: 37301125
[TBL] [Abstract] [Full Text] [Related]
[Next]
